Viking Therapeutics, Inc. (VKTX)
NASDAQ: VKTX · Real-Time Price · USD
26.28
-0.15 (-0.57%)
At close: Jun 18, 2025, 4:00 PM
26.35
+0.07 (0.26%)
After-hours: Jun 18, 2025, 7:56 PM EDT
Viking Therapeutics Employees
Viking Therapeutics had 36 employees as of December 31, 2024. The number of employees increased by 9 or 33.33% compared to the previous year.
Employees
36
Change (1Y)
9
Growth (1Y)
33.33%
Revenue / Employee
n/a
Profits / Employee
-$3,562,111
Market Cap
2.95B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
VKTX News
- 16 days ago - Altimmune Vs. Viking Therapeutics: Evaluating Pipeline Maturity, And Takeover Potential - Seeking Alpha
- 23 days ago - Viking Therapeutics: Buy It For The Future And Ignore The Noise - Seeking Alpha
- 4 weeks ago - Viking Therapeutics: Weight-Loss Story Remains Intact - Seeking Alpha
- 4 weeks ago - Viking Therapeutics: A High Potential Biotech Play With Manageable Risks - Seeking Alpha
- 4 weeks ago - Viking Therapeutics: Near-Term Catalysts And Competitor Readouts - Seeking Alpha
- 2 months ago - Viking Therapeutics: Q1 Earnings Overview - Hard To Understand Wall Street's Pessimism - Seeking Alpha
- 2 months ago - Viking Therapeutics, Inc. (VKTX) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Viking Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update - PRNewsWire